You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PI3Kδ

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
Feb 10, 2022

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
Apr 22, 2022

Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

Not yet recruiting
  • Peripheral T-Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 26, 2021

Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
Oct 3, 2022

Inert Non Hodgkin's Lymphoma Trial in Beijing (IBI376, Rituximab)

Recruiting
  • Inert Non Hodgkin's Lymphoma
  • Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Feb 19, 2022

Solid Tumor, Adult, Non-Hodgkin Lymphoma, Adult, NSCLC Trial in Rozzano, Siena, Glasgow (IOA-244, Avelumab Injection,

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Rozzano, Milan, Italy
  • +2 more
May 13, 2022

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Lymphoid Malignancies Trial in Amsterdam (Idelalisib)

Terminated
Has Results
  • Lymphoid Malignancies
  • Amsterdam, Netherlands
    (unnamed)
Feb 18, 2020

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +49 more
Sep 21, 2022

Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • Failure of Two Rounds of Treatment
  • Zhoukou, Henan, China
  • +1 more
Jan 7, 2023

Lymphoma Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
Oct 14, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Improving Prostate Lesion Classification and Development

Completed
  • Prostate Cancer
    • Nuernberg, Germany
      Department of Radiology and Nuclear Medicine, Klinikum Nuernberg
    Nov 2, 2023

    Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)

    Recruiting
    • Activated PI3K-delta Syndrome
    • Immunodeficiency Primary
    • Shanghai, Shanghai, China
    • +1 more
    Mar 21, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Activated PI3Kdelta Syndrome (APDS); PASLI Disease Trial in Worldwide (CDZ173)

    Active, not recruiting
    • Activated PI3Kdelta Syndrome (APDS); PASLI Disease
    • Bethesda, Maryland
    • +7 more
    Jul 22, 2022

    Alzheimer Trial in Hialeah, Maitland, Winter Park ([18F]PI-2620)

    Recruiting
    • Alzheimer Disease
    • Hialeah, Florida
    • +2 more
    Jan 18, 2023

    Urinary Tract Infection, Acute Pyelonephritis Trial (TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion)

    Not yet recruiting
    • Urinary Tract Infection
    • Acute Pyelonephritis
    • (no location specified)
    Sep 22, 2023

    Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

    Active, not recruiting
    • Advanced Cancers
    • Solid Tumors
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 16, 2022

    Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

    Not yet recruiting
    • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
    • Zhoukou, Henan, China
    • +1 more
    Dec 22, 2022

    Hyperglycemia Drug Induced Trial in Durham (REMD-477)

    Terminated
    • Hyperglycemia Drug Induced
    • REMD-477
    • Durham, North Carolina
      Duke University Medical Center
    Nov 4, 2022

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

    Completed
    • PIK3CA Mutation-Related Tumors
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 9, 2023

    Metastatic Breast Cancer Trial in East Melbourne (BYl719)

    Completed
    • Metastatic Breast Cancer
    • East Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Aug 11, 2022